Bon Natural Life
1 hedge funds and large institutions have $167K invested in Bon Natural Life in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
1,332% more capital inflows, than outflows
Capital inflows: $213K | Capital outflows: $14.9K
4.7% more ownership
Funds ownership: 0.26% → 4.96% (+4.7%)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$213K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14.9K |
BON Hedge Fund Activity: Q2 2024 in Review
1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bon Natural Life (BON) for Q2 2024, worth a combined $167K — up 1,016% from $15K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BON and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $213K. The largest seller was Citadel Advisors, exiting entirely with an estimated $14.9K sold.
- 1 institutional investor held Bon Natural Life (BON) as of Q2 2024, down from 2 in Q1 2024.
- Funds reported $167K of Bon Natural Life stock for Q2 2024, up 1,016% quarter-over-quarter.
- 0 funds opened new Bon Natural Life positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest Bon Natural Life buyer in Q2 2024 was UBS Group, an estimated $213K added.
- The largest Bon Natural Life seller in Q2 2024 was Citadel Advisors, an estimated $14.9K sold.
Based on aggregated 13F filings for Q2 2024.